Blast Crisis - 24 Studies Found Status Study Completed Study Name: An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis Condition: Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis Date: 2005-09-12 Interventions: Drug: imatinib mesylate Other Name: Gleevec/Glivec Completed Study Name: Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate Condition: Chronic Myeloid Leukemia Blast Crisis Date: 2005-01-13 Interventions: Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, Until disease progression or intolerable toxicity, sw Terminated Study Name: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia Condition: Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Date: 2001-09-13 Interventions: Biological: bevacizumab Given Completed Study Name: An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condition: Leukemia, Myeloid, Chronic Date: 2007-10-01 Interventions: Drug: Glivec®/Gleevec® Chemotherapy Completed Study Name: STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis Condition: Leukemia Date: 2000-11-06 Interventions: Drug: imatinib mesylate No longer available Study Name: Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant Condition: Chronic Myelogenous Leukemia Date: 2006-12-18 Interventions: Drug: nilotinib Approved for marketing Study Name: Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condition: Chronic Myeloid Leukemia Date: 2009-05-18 Interventions: Drug: Nilotinib Completed Study Name: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis) Condition: Leukemia, Myeloid, Chronic Date: 2007-03-20 Interventions: Drug: panobinostat LBH589 Completed Study Name: A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condition: Chronic Myeloid Leukemia Date: 2010-05-18 Interventions: Drug: Nilotinib Completed Study Name: Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condition: Chronic Myeloid Leukemia Date: 2008-11-05 Interventions: Drug: Nilotinib Next >>>
